Devangere Devanand

879 total citations
14 papers, 682 citations indexed

About

Devangere Devanand is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Devangere Devanand has authored 14 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 3 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Devangere Devanand's work include Dementia and Cognitive Impairment Research (12 papers), Schizophrenia research and treatment (4 papers) and Alzheimer's disease research and treatments (3 papers). Devangere Devanand is often cited by papers focused on Dementia and Cognitive Impairment Research (12 papers), Schizophrenia research and treatment (4 papers) and Alzheimer's disease research and treatments (3 papers). Devangere Devanand collaborates with scholars based in United States, Canada and Netherlands. Devangere Devanand's co-authors include José A. Luchsinger, Nicole Schupf, Jennifer J. Manly, Richard Mayeux, Edo Richard, Christiane Reitz, Renée D. Goodwin, Karen Marder, Lawrence S. Honig and Ming‐Xin Tang and has published in prestigious journals such as Movement Disorders, Journal of Alzheimer s Disease and British Journal of Clinical Pharmacology.

In The Last Decade

Devangere Devanand

13 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devangere Devanand United States 11 459 148 88 82 71 14 682
Antoni Turon Estrada Spain 15 445 1.0× 164 1.1× 76 0.9× 57 0.7× 50 0.7× 33 687
Carol Dillon Argentina 12 331 0.7× 123 0.8× 48 0.5× 104 1.3× 36 0.5× 32 600
Maira Tonidandel Barbosa Brazil 16 295 0.6× 121 0.8× 28 0.3× 81 1.0× 67 0.9× 60 831
Annette Lolk Denmark 17 464 1.0× 222 1.5× 30 0.3× 97 1.2× 44 0.6× 38 881
Tirso Ventura Spain 6 355 0.8× 147 1.0× 35 0.4× 102 1.2× 92 1.3× 14 736
Barbara Vicini Chilovi Italy 14 636 1.4× 217 1.5× 85 1.0× 180 2.2× 27 0.4× 23 917
Simona Sacuiu Sweden 18 449 1.0× 171 1.2× 25 0.3× 126 1.5× 79 1.1× 40 762
Valerie Smith‐Gamble United States 18 499 1.1× 341 2.3× 50 0.6× 41 0.5× 103 1.5× 21 961
Claire Barkley United Kingdom 6 285 0.6× 114 0.8× 65 0.7× 43 0.5× 38 0.5× 6 473
Vineeth John United States 4 631 1.4× 329 2.2× 131 1.5× 157 1.9× 83 1.2× 5 1.2k

Countries citing papers authored by Devangere Devanand

Since Specialization
Citations

This map shows the geographic impact of Devangere Devanand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devangere Devanand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devangere Devanand more than expected).

Fields of papers citing papers by Devangere Devanand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devangere Devanand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devangere Devanand. The network helps show where Devangere Devanand may publish in the future.

Co-authorship network of co-authors of Devangere Devanand

This figure shows the co-authorship network connecting the top 25 collaborators of Devangere Devanand. A scholar is included among the top collaborators of Devangere Devanand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devangere Devanand. Devangere Devanand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
2.
Park, David S., Xinyang Feng, Adam M. Brickman, et al.. (2021). Deep learning improves utility of tau PET in the study of Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 13(1). e12264–e12264. 8 indexed citations
3.
Pollock, Bruce G., Benoit H. Mulsant, Devangere Devanand, et al.. (2016). R‐ and S‐citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation. British Journal of Clinical Pharmacology. 82(3). 784–792. 30 indexed citations
4.
Weintraub, Daniel, Lea T. Drye, Anton P. Porsteinsson, et al.. (2015). Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease. American Journal of Geriatric Psychiatry. 23(11). 1127–1133. 19 indexed citations
5.
Richard, Edo, Christiane Reitz, Nicole Schupf, et al.. (2012). Late-Life Depression, Mild Cognitive Impairment, and Dementia. JAMA Neurology. 70(3). 383–383. 310 indexed citations
6.
Devanand, Devangere, Joseph H. Lee, José A. Luchsinger, et al.. (2012). Lessons from Epidemiologic Research about Risk Factors, Modifiers, and Progression of Late Onset Alzheimer's Disease in New York City at Columbia University Medical Center. Journal of Alzheimer s Disease. 33(s1). S447–S455. 13 indexed citations
7.
Luchsinger, José A., Lawrence S. Honig, Ming‐Xin Tang, & Devangere Devanand. (2008). Depressive symptoms, vascular risk factors, and Alzheimer's disease. International Journal of Geriatric Psychiatry. 23(9). 922–928. 46 indexed citations
8.
Goodwin, Renée D. & Devangere Devanand. (2008). Stroke, Depression, and Functional Health Outcomes Among Adults in the Community. Journal of Geriatric Psychiatry and Neurology. 21(1). 41–46. 32 indexed citations
9.
Louis, Elan D., Karen Marder, Matthias H. Tabert, & Devangere Devanand. (2007). Mild Parkinsonian signs are associated with lower olfactory test scores in the community‐dwelling elderly. Movement Disorders. 23(4). 524–530. 15 indexed citations
10.
Rutherford, Bret R., Joel R. Sneed, Rachel Eisenstadt, et al.. (2007). An open trial of aripiprazole augmentation for SSRI non‐remitters with late‐life depression. International Journal of Geriatric Psychiatry. 22(10). 986–991. 39 indexed citations
11.
Pelton, Gregory H., Devangere Devanand, Karen L. Bell, et al.. (2003). Usefulness of Plasma Haloperidol Levels for Monitoring Clinical Efficacy and Side Effects in Alzheimer Patients With Psychosis and Behavioral Dyscontrol. American Journal of Geriatric Psychiatry. 11(2). 186–193. 6 indexed citations
12.
Albert, Steven M., et al.. (2002). The impact of mild cognitive impairment on functional abilities in the elderly. Current Psychiatry Reports. 4(1). 64–68. 36 indexed citations
13.
Stern, Yaakov, M. F. Folstein, Marilyn Albert, et al.. (1993). Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons. Alzheimer Disease & Associated Disorders. 7(1). 3–21. 86 indexed citations
14.
Richards, Marcus, M. F. Folstein, Marilyn Albert, et al.. (1993). Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease Severity. Alzheimer Disease & Associated Disorders. 7(1). 22–32. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026